{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-002326","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.520243+00:00","generated_at":"2026-05-16T10:12:17.927935+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Aspire Biopharma Board sets share limit for 2024 Stock Incentive Plan at 4,890,000 shares","bullets":["Board confirmed share limit of 4,890,000 shares for the 2024 Stock Incentive Plan, which was approved by stockholders in Feb 2025.","Approved forms of Restricted Stock Unit and Stock Option award agreements under the Plan.","Plan allows grants of equity awards to employees, directors, and consultants to align with long-term stockholder interests."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-002326","json":"https://secwatch.observer/filing/0001493152-26-002326.json","markdown":"https://secwatch.observer/filing/0001493152-26-002326.md","text":"https://secwatch.observer/filing/0001493152-26-002326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226002326/0001493152-26-002326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226002326/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:12:17.927935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}